Skip to main content
FinSpry Logo
FinSpry
MRNA logo
MRNA
(NASDAQ)
Moderna, Inc.
$145.55-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Moderna (MRNA) Stock Price & Financial Analysis

Moderna Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$141.52 - $154.69
52-Week High$176.66
52-Week Low$22.28
Open$153.62
Volume14.91M
Average Volume (3M)24.09M
Market Cap57.93B
Shares Outstanding398.00M
Price to Sales (P/S)26.00
Price to Book (P/B)8.57
EV/EBITDA-19.25
Revenue (TTM)2.23B
Net Income (TTM)-3.15B
Free Cash Flow (TTM)-1.22B
EPS (TTM)$-8.00
Profit Margin-141.43%
Operating Margin-149.01%
Return on Equity (ROE)-46.61%
Debt to Equity0.09
50-Day MA$85.50
200-Day MA$54.82
52-Week Change478.96%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Moderna

What is the current stock price for MRNA?

As of the latest trading session, MRNA stock trades at $145.55. The 52-week range is $22.28–$176.66, with a day range of $141.52–$154.69.

What is the P/E ratio for MRNA?

The P/E ratio (Price-to-Earnings) for MRNA is shown in the Key Statistics section. This valuation metric helps compare Moderna, Inc. to industry peers.

Does MRNA pay dividends?

Moderna does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MRNA?

Based on 34 analysts, the consensus for MRNA is Buy.

What is the market cap of MRNA?

Moderna's market capitalization is $57.93B, classifying it as a large-cap company. Moderna operates in the Healthcare sector within the Biotechnology industry.